Articles

Page 12 of 19

NRTI backbone pairs for treatment-naïve adults with HIV infection: a UK economic evaluation

Authors: AJ Brogan, F Everhard, SE Talbird, E Hutt and E Zimovetz

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P306

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Distribution of autoantibodies and rheumatological manifestations in HIV-positive patients from the University Clinic of Bonn – a pilot study

Authors: EA Becker, JC Wasmuth, E Voigt, C Schwarze-Zander, J Emmelkamp and J Rockstroh

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P304

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Sexual dysfunction in HIV-infected women: prevalence and related factors

Authors: AM Guelar, J Villar, ML Sorlí, M Velat, O Urbina, A Gonzalez and H Knobel

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P302

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Age-related co-morbidities in people living with HIV

Authors: G Guaraldi, S Zona, G Orlando, N Squillace, C Stentarelli, G Nardini, B Beghetto, R Esposito and FJ Palella

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P300

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
What about primary pulmonary hypertension in HIV infection in the era of combination antiretroviral therapy?

Authors: M Mary-Krause, C Lascoux-Combe, A Simon, E Teicher and D Costagliola

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P299

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Safety and tolerability of etravirine (ETR; TMC125) in hepatitis B and/or C co-infected patients in DUET-1 and DUET-2: pooled 48-week results

Authors: B Clotet, C Katlama, A Lazzarin, K Jansen, TN Kakuda and G De Smedt

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P272

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Acute hepatitis C infection in a cohort of HIV-infected patients in Belgium

Authors: E Florence, E Bottieau, M Van Den Boer, M Vekemans, S Francque, E Vlieghe, P Soentjens and R Colebunders

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P270

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
HCV relapse after peg-interferon (IFN) plus ribavirin (RBV) therapy: is 12-week follow-up enough to determine sustained HCV clearance?

Authors: J Medrano, S Resino, E Vispo, P Tuma, J García-Samaniego, L Martin-Carbonero, P Labarga, I Jimenez, M Romero, P Barreiro and V Soriano

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P268

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Rapid virological response is the best predictor for achieving SVR under peg-IFN/ribavirin hepatitis C therapy in HIV/HCV co-infected patients

Authors: M Janke, G Luechters, M Vogel, E Voigt, JC Wasmuth, C Schwarze-Zander, J Emmelkamp, G Fätkenheuer and J Rockstroh

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P266

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Cross-sectional study to determine prevalence of significant liver fibrosis (F2–F4) in HIV/HCV co-infected patients: GRAFIHCO study

Authors: C Tural, E Ortega, JA Pineda, J Gonzalez-García, L Griffa, E Cabrero and A Burgos

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P264

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Predictors of severe hyperbiliruniaemia in HIV-infected patients treated with atazanavir (ATV)

Authors: M Casana, A Barassi, P Cicconi, T Bini, L Comi, O Turri, F Pateri, ML Biondi, GL Melza d'Eril and A d'Arminio Monforte

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P235

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Plasma concentrations of boosted and unboosted atazanavir are predicted by 63396C>T SNP in the PXR gene

Authors: M Siccardi, A D'Avolio, L Baietto, A Calcagno, SE Gibbons, M Sciandra, S Bonora, SH Khoo, DJ Back, G Di Perri and A Owen

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P233

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Ten years of non-occupational HIV post-exposure prophylaxis: what have we learned?

Authors: F Tissot, V Fardel and M Cavassini

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P231

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Clinical mentoring: a sustainable strategy for scaling up HIV/AIDS clinical expertise in developing countries

Authors: S Aggett, K Shantz, R Mair and M Charles

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P229

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
HIV maternal-fetal transmission in a low resources setting in the outskirts of Buenos Aires, Argentina

Authors: M Hojman, F Murano, G Manonelles, M Maldonado, N Ahmed, M Sanchez Vera and M Prieto

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P227

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Elite controllers or misquantification of virus load by Cobas TaqMan?

Authors: N Taylor, M Jauer, K Bijuklic, A Egle, R Greil, W Patsch, M Obermeier and J Eberle

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P200

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Therapeutic drug monitoring of new formulation Kaletra in pregnancy

Authors: V Jackson, LJ Else, SH Khoo, SE Gibbons, M Brennan, EO Connor, N Boyle, C Fleming, S Coulter-Smith and J Lambert

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P199

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Validation of an enhanced sensitivity Trofile™ HIV-1 co-receptor tropism assay for selecting patients for therapy with entry inhibitors targeting CCR5

Authors: L Trinh, D Han, W Huang, T Wrin, J Larson, L Kiss, E Coakley, CJ Petropoulos, N Parkin, JM Whitcomb and JD Reeves

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P197

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
HIV treatment decision making: high rate of revised treatment choices based upon different genotypic interpretation systems

Authors: E Wolf, E Gersbacher, M Vogel, A Eberhard, J Goelz, Y Yazdanpanah, J Rockstroh, G Fätkenheuer, S Mauss, C Mayr, H Knechten, I Van Walle, E Jaegel-Guedes and H Jaeger

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P195

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Patterns of drug resistance mutations after failure of first-line NNRTI-based antiretroviral therapy in Western India

Authors: SN Pujari, AN Dravid, N Gupte, A Makne, S Gaikwad, P Mukhopadhaya, B Aich and V Bele

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P193

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Evaluation of adherence and toxicities to HAART in a cohort of HIV+ immigrant patients in south-eastern Spain during the period 1998–2007

Authors: FJ Vera-Méndez, J Trujillo-Santos, A Cano-Sánchez, JA García-Henarejos, J García-García, OJ Martínez-Madrid, R Vilaplana-García, C Pérez-Pagán, N Cobos-Trigueros, M Alcalde-Encinas and V Herrero-Segastume

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P164

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
HIV patients' gastrointestinal tolerability and treatment satisfaction after switching from lopinavir/ritonavir (LPV/r) SGC to co-formulated LPV/r tablets

Authors: J Borras-Blasco, JD Rosique-Robles, A Belda, FJ Abad and MDE Castera

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P162

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Health-related quality of life in HIV-infected patients in a private practice in Germany

Authors: S Mauss, J Henke, F Berger, P Hegener and G Schmutz

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P160

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Study of HIV-positive patients with asymptomatic retroperitoneal lymphadenopathy on antiretroviral therapy for the development of IRIS

Authors: AK Tripathi, N Gupta and M Khanna

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P158

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Gender differences in depression evolution in a cohort of patients attending a metabolic clinic for lipodystrophy management

Authors: G Orlando, N Squillace, I Mazeu, B Beghetto, G Nardini and G Guaraldi

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P156

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Lipid elevations in the ARTEMIS and TITAN trials: effects of demographics, HIV disease stage, treatment arm and lipid-lowering drugs

Authors: M Nelson and AM Hill

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P127

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Statistical agreement between ATPIII, IDF, EGIR, AACE metabolic syndrome classifications in HIV-infected patients and association with lipodystrophy

Authors: G Guaraldi, S Zona, R D'Amico, N Squillace, G Orlando, C Stentarelli and R Esposito

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P125

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
PI and OPG/RANKL levels in human osteoblast cells

Authors: M Borderi, D Gibellini, L Tampellini, C Biagetti, F Vescini, MC Re and F Chiodo

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P123

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Lipid changes in patients receiving nevirapine (NVP) in combination with tenofovir/emtricitabine: results from the CCIAT trial

Authors: C Davis, R Talwani, B Gilliam, A Amoroso, C Boyce, P Piliero, C Conner and R Redfield

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P121

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Assessment for sonographic grading scales of the body fat changes related to the lipoatrophic findings of HIV patients in treatment with HAART

Authors: R Gulizia, C Gervasoni, M Ortu, M Galli and C Filice

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P119

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Body physical changes in HIV patients under antiretroviral treatment in Spain

Authors: L Griffa, E Cabrero and A Burgos

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P117

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Impact of fasting bloods on hypertriglyceridemia

Authors: NA Billing, GJ Moyle and M Nelson

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P98

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Virological treatment outcome under HAART: does sex matter?

Authors: AE Haberl, S Usadel, N Hanhoff and S Holm

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P71

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Efficacy and tolerability of long-term nevirapine plus nucleoside reverse transcriptase inhibitors for HIV-1 infection

Authors: CA Carocci, MC Martinelli, MV Mastronardi, CP Corsi and LF Leoncini

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P69

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Saquinavir/ritonavir monotherapy as a new nucleoside-sparing maintenance strategy

Authors: P Echeverría, P Domingo, M Gutierrez, G Mateo, J Puig, J Moltó, N Pérez-Álvarez, B Clotet and E Negredo

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P67

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Abacavir/lamivudine has shown similar efficacy to other nucleoside conventional combinations in previously HIV-infected patients: results at 48 weeks

Authors: P Echeverría, J De la Torre, J Pasquau, E Casas, T Puig, E Ribera, I Bravo, R López, B Clotet and E Negredo

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P65

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Patient-reported outcomes after simplification to a single tablet regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir DF (TDF)

Authors: S Hodder, K Mounzer, E DeJesus, JF Maa, R Ebrahimi, K Grimm, JF Flaherty and A Farajallah

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P63

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Once-daily saquinavir (SAQ)/ritonavir (RTV) (2000/100 mg) with abacavir/lamivudine (600/300 mg) or tenofovir/emtricitabine (245/300 mg) in naïve patients

Authors: M Bickel, A Bodtlaender, G Knecht, M Kurowski, S Klauke and T Lutz

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P59

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Different metabolic and anthropometric characteristics of TVD, CBV or KVX associated with nevirapine: Results from the "NEVIRAPINE COMPANION" cohort

Authors: G Guaraldi, F Adorni, S Zona, N Squillace, G Orlando, C Stentarelli, R Esposito and C Sconiamilio

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P34

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Virological and immunological response to three boosted protease inhibitor regimens

Authors: C Baumgardt, C Stephan, AE Haberl, HR Brodt, M Stuermer, S Klauke, P Gute, M Bickel, P Khaykin, N von Hentig and S Staszewski

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P32

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
CD4+ guided antiretroviral treatment interruption. A meta-analysis

Authors: A De Silvestri, A Boschi, C Tinelli and E Seminari

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P30

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Patient retention on antiretroviral therapy programme: risk factor analysis of a Uganda cohort

Authors: EJ Mills, P Olupot-Olupot, C Cooper, J Meadway, H Boorman, A Das and JSO Obbo

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P28

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
O233 Surrogate markers for liver damage (i.e. how can we measure the extent of fibrosis and disease without biopsy)

Authors: M Puoti

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O26

Content type: Oral presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Tipranavir in highly ARV-experienced patients: efficacy and tolerability results from the French prospective NADIS cohort

Authors: C Allavena, P Flandre, P Pugliese, MA Valantin, J Izopet, R Garraffo, I Poizot, A Cabie, Y Yazdanpanah, L Cuzin, C Duvivier, C Katlama and P Dellamonica

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P26

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
O231 Cryptogenetic liver disease, steatosis, portal hypertension, transaminitis and antiretrovirals

Authors: S Pol

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O24

Content type: Oral presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
O213 CD4-guided STI in patients responding to HAART

Authors: F Maggiolo, M Airoldi, A Callegaro, C Martinelli, A Dolara, T Bini, G Gregis, P Quinzan, V Ravasio and F Suter

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O18

Content type: Oral presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
O122 Prevalence of drug interactions between antiretroviral and co-administered drugs at the Moi teaching and referral hospital (Ampath), Eldoret, Kenya

Authors: GK Kigen, S Kimaiyo, DJ Back, SE Gibbons, E Sang, IG Edwards, A Owen and SH Khoo

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O7

Content type: Oral presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
O115 Importance of detecting minority variants in the clinical management of HIV

Authors: D Kuritzkes

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O5

Content type: Oral presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
O113 HIV-1 clade C resistance genotypes after first virological failure in a large community ART programme

Authors: C Orrell, RP Walensky, E Losina, KA Freedberg and R Wood

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O3

Content type: Oral presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF
Clinical effect of interleukin-2 (IL-2) immuno-adjuvant treatment in HIV+ advanced naïve patients

Authors: C Tincati, M Cesari, L Meroni, F Bai, GM Bellistrì, M Galli, ME Moroni, A d'Arminio Monforte and GM Marchetti

Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P1

Content type: Poster presentation Published on: 10 November 2008

This article is part of a Supplement: Volume 11 Supplement 1
- View Full Text
- View PDF

How was your experience today?

Rating Please select one rating

Awful

Bad

Good

Great

Thank you for your feedback.

Tell us why (opens in a new tab)

Articles

Journal of the International AIDS Society